Family ID | Mutation | Sex of proband | Phenotype proband (age Dx) | Tumor type | IHC | Familial history of breast cancer and ovarian cancer (age Dx) | Other cancers in the family (age Dx) |
---|---|---|---|---|---|---|---|
147 | Exon5-7dup | Female | 43 | IDC | ER−/PR−/HER2- | S OC (48) | None |
10 | Exon13-14dup | Female | 29 | MpBC | ER−/PR−/HER2- | M BC(57), PGM BC | None |
213 | Exon13-14dup | female | 33 | IDC | ER+/PR−/HER2- | PA OC(53) and BC(56), MGM BC (52) | None |
113 | Exon1-22del | Female | 45 (R), 50 (L) | BMC (R), IDC (L) | R: ER−/PR−/HER2+ L: NA | S BC (42) and OC (45) | F EC (71), MU BlaC (71), MB Leu |
203 | Exon1–24(part)del | Female | 39 | MBC | ER−/PR−/HER2- | M BC (50), MS BC (43) | None |